The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,799.50
Bid: 1,796.00
Ask: 1,796.50
Change: 19.00 (1.07%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,799.50
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: On The Beach adds Justine Greening to board

Fri, 05th Mar 2021 15:10

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News:

----------

On The Beach Group PLC - Manchester-based online retailer of beach holidays - Hires former UK government minister Justine Greening as non-executive director, effective immediately. Greening served as transport secretary between 2011 and 2012 and as education secretary from 2016 to 2018 before leaving government that year. Before her political career, during which she represented Putney in west London, Greening was an accountant with PriceWaterhouse and held a strategy role at GlaxoSmithKline PLC. "It is a privilege that Justine has chosen On the Beach as her first corporate non-executive director role, and we look forward to working with her and benefiting from her extensive knowledge and expertise," says Chair Richard Pennycook. "As the travel sector recovers from the pandemic, we expect some fairly major reforms to the regulatory landscape. Justine's experience, in and out of Westminster, will be invaluable as On the Beach navigates these reforms and pursues opportunities to grow our market share both in the UK and internationally."

----------

K3 Business Technology Group PLC - Manchester-based enterprise software firm - Adalsteinn Valdimarsson steps down as chief executive officer, effective immediately. Chair Tom Crawford will be interim CEO while a replacement is found. K3 says departure follows the disposal of Starcom Technologies Ltd, which strengthened the company's financial position and allowed it to move onto a new phase of development. K3 sold Starcom last month to infrastructure and services company Node4 Ltd for GBP14.7 million in cash. Will provide an update on the recruitment process at its annual results on March 30.

----------

Andrews Sykes Group PLC - Wolverhampton-based heating and cooling rental company - Confirms Carl Webb as managing director. Webb was made interim MD in January, having been MD of the UK business for 15 years. Webb replaces Paul Wood, who died at the end of January.

----------

Sabien Technology Group PLC - Maidenhead, England-based energy efficiency technology - Promotes Edward Sutcliffe to chief financial office and board director, effective immediately. Sutcliffe has been interim finance director and company secretary since June 2017.

----------

IG Group Holdings PLC - London-based contracts-for-difference trading platform - Hire Lisa Pollina as non-executive director, starting immediately. Pollina is on the board of insurer Munich RE AG, representing the Americas. She also was vice chair of RBC Capital Markets, part of Royal Bank of Canada.

----------

Surface Transforms PLC - Liverpool-based maker of automotive brake discs - Matthew Taylor and Julia Woodhouse added to board as non-executive directors, both effective immediately. Taylor retired last year as CEO of Bekaert SA, a Belgium-based steel wire business. Woodhouse retired from Ford Motor Co in 2018, having served as director of Global Power Train Purchasing, based in the US, and director of Global Chassis Purchasing, based in Germany.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.